Drug makers’ profitability worsen on aggressive promotion

Domestic pharmaceutical firms, which have increased their revenues during the last few years, are seeing profitability worsen on aggressive promotion.

Yakup com. said most of Korean drug manufacturers are seeing their profitability worse due to on excessive marketing and rebate offerings to hospitals.

Dongsung spent 54 percent of its first-quarter revenue on promotion in the first quarter...